FCM demonstrated that HPP was recognized by TLR2 and activated NF-κB and nucleotide-binding domain, leucine-rich-containing family, pyrin domain–containing-3 (NLRP3) signaling pathways, thereby enhancing the host immune system and exerting anti-tumor effects (Liu et al., 2020). This evidence concerns the gene NFKB1 and neoplasm.